Human Umbilical Stem Cells and Derivatives Learn More Unique Products with Cell Derivatives Available Learn More Research and Clinical Grade TRT Cells Available Learn More

Welcome to Tissue Regeneration Therapeutics (TRT)

Tissue Regeneration Therapeutics (TRT) is a Canadian life science company based on proprietary, and patented, human umbilical cord tissue technologies that provide a comprehensive product portfolio from skin care products to cell based, and cell engineered, therapeutics. TRT has discovered the world’s richest source of mesenchymal stromal/stem cells (MSCs) with potent regenerative, angiogenic, anti-inflammatory, and immuno-regulatory properties. Unique advantages of the TRT HUCPVC platform technology are founded on the highly enriched source of these important cells compared to other tissue sources.

WHAT WE DO

We Build Very Powerful Biology

With our partners we create cellular and regenerative strategies that maximize the utility of our platform technology and products – for therapies that address important health care issues of today. Together, we build very powerful biology.

3circles w bg

The 3 Platforms

Read More
single-small

The Cell Derivative Platform

Read More
platform3

The TXP Platform

Read More
platform4

The eTXP Platform

Read More
70
Patents
32
Our Publications
18
Other Publications
15
Collaborators

ABOUT US

A Progressive Biotechnology Company

Tissue Regeneration Therapeutics (TRT) is a progressive biotechnology company with a focus on the commercial development of our patented Human Umbilical Cord PeriVascular Cell (HUCPVC) platform technology and its TXP cell therapy products.

partner1
logo2
logo9
logo8
logo7
logo6
logo5
logo4
logo3

BLOG UPDATES

TRT News